Gr. Pitcairn et al., Pulmonary drug delivery from the Taifun dry powder inhaler is relatively independent of the patient's inspiratory effort, J AEROSOL M, 13(2), 2000, pp. 97-104
Citations number
27
Categorie Soggetti
Envirnomentale Medicine & Public Health
Journal title
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG
The Taifun(R) dry powder inhaler (Leiras OY, Turku, Finland) is a breath-ac
tuated, multidose device, each metered dose containing 200 mu g of budesoni
de. A two-way randomized crossover gamma scintigraphic study was performed
in 10 asthmatic patients to determine the in vivo deposition pattern of bud
esonide inhaled from the Taifun(R). In vituo radiolabelling validation stud
ies demonstrated that the radiolabel could be used as an accurate marker to
assess in vivo drug deposition. Patients used either maximal inspiratory e
ffort (targeted peak inhalation flow 30 L/min) or submaximal inspiratory ef
fort (targeted peak inhalation flow 15 L/min) on each study day. Mean (S.D.
) whole lung deposition (% of metered dose) was 34.3 (5.8)% and 29.6 (5.9)%
for the two inhalation flows. The intersubject coefficient of variation in
lung deposition was less than 20% on both study days. Drug was deposited u
niformly across the central, intermediate, and peripheral lung regions for
maximal and submaximal inspiratory efforts. The study suggests that the Tai
fun(R) is a superior drug delivery device compared with many other inhalers
, in terms of the amount of drug deposited in the lungs, the reproducibilit
y of the lung dose, and the relative flow-independence of lung deposition.